A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PS / particle size

[Related PubMed/MEDLINE]
Total Number of Papers: 123
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PS  (>> Co-occurring Abbreviation)
Long Form:   particle size
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Cork as a sustainable carbon source for nature-based solutions treating hydroponic wastewaters - Preliminary batch studies. CT, NBS, OC
2018 A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation. ALM, i.n, PDI, SLNs
2018 A potential antibacterial wound dressing of cefadroxil chitosan nanoparticles in situ gel: Fabrication, in vitro optimization and in vivo evaluation. CDX, PDI, ZP
2018 Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers. ARM, CM, EE, HSH, NLCs, ZP
2018 Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation. CRC, DSC, DSPE, EE, FA, OP, OPSLNFs, OPSLNs, SLNs, XRD
2018 Corneal targeted Sertaconazole nitrate loaded cubosomes: Preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. PDI, STZ, STZ-CUBs, ZP
2018 Design, optimization and characterizations of chitosan fortified calcium alginate microspheres for the controlled delivery of dual drugs. EE
2018 Development and optimization of a novel drug free nanolipid vesicular system for treatment of osteoarthritis. EA, NLVS, OA, PC, PDI, SC, ZP
2018 Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design. ADC, BBD, DSB, PBD, PEG, ZP
10  2018 Effect of homogenisation speed and centrifugation on particle size analysis of beef and the relationship with shear force. LL
11  2018 Effect of long term chilled (up to 5 weeks) then frozen (up to 12 months) storage at two different sub-zero holding temperatures on beef: 3. Protein structure degradation and a marker of protein oxidation. LL
12  2018 Effects of feed form and particle size, and pellet binder on performance, digestive tract parameters, intestinal morphology, and cecal microflora populations in broilers. CD, FF, GC, LAB, PB, PDI, STC, VH
13  2018 Effects of forage source and forage particle size as a free-choice provision on growth performance, rumen fermentation, and behavior of dairy calves fed texturized starters. AH, AH-LPS, AH-MPS, WS-LPS, WS-MPS
14  2018 Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example. DVs, EE, IVs, NVs, OF, ZP
15  2018 Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study. CCFD, LCDP, PDI
16  2018 Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery. BRZ, DL, EE, NLC, PDI, TM
17  2018 Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. DCN, DI, EA, OA, PDI, ZP
18  2018 Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking, Technetium 99m Radiolabeling, and In Vivo Biodistribution Studies. i.t, i.v, MPD, MPDME, MPDS, PDI, ZP
19  2018 Intake and feed utilization in two breeds of pregnant beef cows fed forages with high-fiber concentrations. iNDF, MCP, RC, WCO
20  2018 Lyophilized Hybrid Nanostructured Lipid Carriers to Enhance the Cellular Uptake of Verapamil: Statistical Optimization and In Vitro Evaluation. HVD-NLCs, PDI
21  2018 Metformin-Loaded Hyaluronic Acid Nanostructure for Oral Delivery. HA, ZP
22  2018 Nanoemulsion of Dill essential oil as a green and potent larvicide against Anopheles stephensi. EOs, LA, LC
23  2018 Nanoliposomal Resveratrol as a Novel Approach to Treatment of Diabetes Mellitus. DM, EE, GSH-Px, LPs, MTT, PDI, RSV, SOD, STZ, ZP
24  2018 Nanosized soy phytosome-based thermogel as topical anti-obesity formulation: an approach for acceptable level of evidence of an effective novel herbal weight loss product. ---
25  2018 Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain. EE, GMO, PDI, TEM, ZP
26  2018 PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. EE, MRT, PDI, ZP
27  2018 Resolution V fractional factorial design for screening of factors affecting weakly basic drugs liposomal systems. PhC, ZP
28  2018 Reversing multi-drug tumor resistance to Paclitaxel by well-defined pH-sensitive amphiphilic polypeptide block copolymers via induction of lysosomal membrane permeabilization. CAC, GPC, LMP, PEG-PBLG, PTX-NPs, ROP
29  2018 Skin targeting of oxiconazole nitrate loaded nanostructured lipid carrier gel for fungal infections. GMS, NLC, OCXN, SEM
30  2018 Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization. PDI, SM, STZ, STZ-MMs, ZP
31  2018 Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Dorz, DVs, IOP, OF
32  2018 Synthesis of an oleic acid based pH-responsive lipid and its application in nanodelivery of vancomycin. EE, NMEO, PDI, VCM, ZP
33  2018 Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity. ART, ART-NLCs, EE, MRT, PDI, TF-NLCs, ZP
34  2018 Topical phenytoin nanostructured lipid carriers: design and development. NLCs, PHT, ZP
35  2018 Tri-block co-polymer nanocarriers for enhancement of oral delivery of felodipine: preparation, in vitro characterization and ex vivo permeation. FLD, PDI
36  2017 Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies. AC
37  2017 Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies. CS-NPs, RH, TPD
38  2017 Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. CS, CS-DNS, DCN, DNS, PDI, PVP, ZP
39  2017 Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design. DL, EE, MRT, PTX, PTX-NLCs, Tf-NLCs, ZP
40  2017 Development, stability and in vitro delivery profile of new loratadine-loaded nanoparticles. ---
41  2017 Diosmin/essential oil combination for dermal photo-protection using a lipoid colloidal carrier. LCC
42  2017 Effect of dietary fiber and diet particle size on nutrient digestibility and gastrointestinal secretory function in growing pigs. CSB, DC, DDGS, GIP, GLP-1, SBH, TBA
43  2017 Effect of surfactants and drug load on physico-mechanical and dissolution properties of nanocrystalline tadalafil-loaded oral films. OFs, PDI, TDF, ZP
44  2017 Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design. LCDP, PDI, ZP
45  2017 Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation. LXN, S. aureus, ZP
47  2017 Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study. ALG, CS, FSM, NPs, PDI, SEM, ZP
48  2017 Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. NLCs, SV, ZP
49  2017 Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery. DOE, FA-Chi-MTX NPs, FESEM, HeLa, PSD
50  2017 Resin-dentin bond stability and physical characterization of a two-step self-etching adhesive system associated with TiF4. DC, PI, ZP
51  2017 RSM and ANN modeling-based optimization approach for the development of ultrasound-assisted liposome encapsulation of piceid. ---
52  2017 Screening of ionically crosslinked chitosan-tripolyphosphate microspheres using Plackett-Burman factorial design for the treatment of intrapocket infections. CS-TPP, CT, DSC, DT, EE, FTIR, MOP, PY, SEM, XRD
53  2017 Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity. EE, FA, FA-ODA and PEG-ODA, NLC, PEG, PTX, ZP
54  2017 Titanium tetrafluoride incorporated into a two-step self-etching adhesive system: physico-mechanical characterization and bonding stability. CL, DC, FS, PI, TBS, ZP
55  2017 Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation. DI, FPCa, TFH
56  2016 A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations. EE, PLGA, ZP
57  2016 A trial for the design and optimization of pH-sensitive microparticles for intestinal delivery of cinnarizine. CIN, EE, RE
58  2016 Aripiprazole loaded poly(caprolactone) nanoparticles: Optimization and in vivo pharmacokinetics. APZ
59  2016 Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks. ANN, CS, DSC, FT-IR, NP, TPP, ZP
60  2016 Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. EE, NP
61  2016 Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size. APEs, Chol, DPPC, RSM
62  2016 In vitro and in vivo effect of paclitaxel and cepharanthine co-loaded polymeric nanoparticles in gastric cancer. CCRD, CCRD-RSM, CEP, DL, EE, PTX, RSM
63  2016 Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies. CCFD, CZ, EE, PDI, PM, SE, TFH, ZP
64  2016 Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles. EE, LbL
65  2016 Methotrexate loading in chitosan nanoparticles at a novel pH: Response surface modeling, optimization and characterization. CS, NPs, PDI, ZP
66  2016 Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation. PVA, SLNs, VCM
67  2016 Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers. DSC, LL, LL-NLCs, TEM, XRD, ZP
68  2016 Short communication: The effect of an exogenous enzyme with amylolytic activity on gas production and in vitro rumen starch degradability of small and large particles of corn or barley meals. IVSD
69  2016 Sustained-release genistein from nanostructured lipid carrier suppresses human lens epithelial cell growth. CCK-8, EE, GEN, HLECs, NLC, RT-qPCR, ZP
70  2016 Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system. EE, ETP, FA, FA-ETP-NLCs, NLCs
71  2015 Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design. EE, PDI, QbD
72  2015 Effects of supplementation level and particle size of alfalfa hay on growth characteristics and rumen development in dairy calves. HL, HM, LL, LM
73  2015 Experimental Design to Predict Process Variables in the Microcrystals of Celecoxib for Dissolution Rate Enhancement Using Response Surface Methodology. CLX, CY, DC, Ss
74  2015 Influence of grain particle sizes on the structure of arabinoxylans from brewer's spent grain. AG, AX, DB, DP
75  2015 Injectability of calcium phosphate pastes: Effects of particle size and state of aggregation of beta-tricalcium phosphate powders. LPR, PSD
76  2015 Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity. AD, CS-NPs, PDI, PIP, ZP
77  2015 Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity. AD, CS-NPs, PDI, PIP, ZP
78  2015 Polymer assisted entrapment of netilmicin in PLGA nanoparticles for sustained antibacterial activity. EE, NS, PLGA
79  2015 Rumen fermentation, blood metabolites, and growth performance of calves during transition from liquid to solid feed: Effects of dietary level and particle size of alfalfa hay. AH, H-FPS, H-MPS, M-FPS, M-MPS, TDMI
80  2015 Rutin nanostructured lipid cosmeceutical preparation with sun protective potential. NLC-P, NLCs, RT, SPF
81  2014 Application of multiple regression analysis in optimization of anastrozole-loaded PLGA nanoparticles. DSC, NPs, PDE, TEM
82  2014 Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design. ATDs, CCD, CLSM, FM, PI, PMs, PNs, RIF, RPNs, RSM, SC
83  2014 Effect of moisture on disintegration kinetics during anaerobic digestion of complex organic substrates. AD, TS
84  2014 Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design. NPs
85  2014 In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy. ddI, MMFs, PDI, SLNs
86  2014 Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation. DSC, EE, HPMCP, PDI, ZP
87  2014 Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization. CCD, DEE, PM
88  2014 Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. DCN
89  2014 Predicting tenderness of fresh ovine semimembranosus using Raman spectroscopy. CL, RMSEP, SF, SL
90  2014 Preparation and characterization of rivastigmine loaded human serum albumin (HSA) nanoparticles. AD, ChEI, HSA, NPs, PDE, RT
91  2014 Preparation, characterization and optimization of glipizide controlled release nanoparticles. ACNP, GlACNP, LP, MRT, ZP
92  2014 Raman spectroscopy compared against traditional predictors of shear force in lamb m. longissimus lumborum. CL, LL, PM, RMSEP, SF, SL
93  2013 Application of response surface methodology in development of sirolimus liposomes prepared by thin film hydration technique. Chol, DOPE, DPPC
94  2013 Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. DSC, DSN, DSN, IR, SEM, TEM, XRD
95  2013 Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. SLNs, TH
96  2013 Development of standard operating procedures of Habbe Shifa: A polyherbal Unani formulation. GAM, HS, SOPs
97  2013 Effects of alfalfa hay particle size in high-concentrate diets supplemented with unsaturated fat: chewing behavior, total-tract digestibility, and milk production of dairy cows. AH, DM, DMI, peNDF
98  2013 Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics. cPCL, DSC, EXE, FTIR, NPs, PDE, TEM
99  2013 Formulation and optimization of temozolomide nanoparticles by 3 factor 2 level factorial design. PDE
100  2013 Influence of surface features of hydroxyapatite on the adsorption of proteins relevant to bone regeneration. CS, Fg, FN, SSA